Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SonoVue and Ultrasound in Inoperable Pancreatic Ductal Adenocarcinoma
NCT04146441Phase 2Completed
- Sponsor
- St. Olavs University Hospital
- Start
- Feb 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sulfur hexafluoride in pancreatic ductal adenocarcinoma (PDAC), sponsored by St. Olavs University Hospital. Started Feb 2020; status: completed.
02
Drugs
sulfur hexafluoride
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT04146441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04146441.